THE CLIENT
European private bank
European private bank
THE CHALLENGE
The bank required quick and accurate valuations for their portfolio of OTC derivatives, but did not have the resources to
produce their trade valuations internally. Historically, they had been relying on their counterparty valuations which was
becoming a burdensome operational cost.
THE SOLUTION
The bank found the triCalculate Valuation service to be a transparent, dependable and truly independent provider of OTC
derivative valuations. The results of the client’s daily independent valuations have been easily adapted for their internal
workflows. They are now able to challenge and dispute their counterparty valuations where they see fit.
COVERAGE
The client has an OTC derivative portfolio consisting of FX, interest rates and commodities. triCalculate provides coverage for vanilla and exotic instruments across asset classes and currencies.
MARKET DATA
triCalculate valuations are calculated using a combination of NEX Market Data and data from Thomson Reuters. The use of market data is included in the triCalculate Valuation fee. The data is rigorously cleansed and validated to ensure quality for the valuation process.
COST
For the client, an important factor in choosing a valuation provider was overall cost of the service. The bank conducted a cost benefit analysis, and triCalculate was deemed the most cost-efficient solution available.
SPEED
The client was up and running with triCalculate Valuation and began receiving valuations for their cross-asset OTC portfolio in less than 30 days.
SUPPORT
The triCalculate team interprets and maps clients’ data, so they don’t have to. We ensure results are easily accessible and simple to understand, helping reduce clients’ operational burden.
SEAMLESS SOLUTION
Clients can send their trade data and valuations from triCalculate directly to triResolve. When in scope for Initial Margin, clients can get their SIMM Sensitivities from triCalculate with seamless connectivity to triResolve Margin and AcadiaSoft's IM Exposure Manager.
“For a number of reasons we decided to utilise a service to give us independent valuations for our OTC derivatives in our portfolio. First we looked to providers that have been in the market for some time. Our main problem with those is that they are expensive and their customer service was a bit complacent. The service we receive from the triCalculate team is exceptional and the fee we pay is half that from the other providers.”
